New Technology– category –
-
Precision Oncology Unleashed: Tumor-Specific Promoters and Nanocarriers Drive Next-Gen Gene Therapy, LNP-Based mRNA/siRNA Therapies Paving the Way
MDPI Switzerland Overview Precision cancer gene therapy is being transformed by the integration of tumor-specific promoters and nanodelivery systems, significantly enhancing therapeutic specificity. A range of nanocarriers, including LNP... -
Unlocking Next-Gen Wearables: Nanocomposites Enhance Chip Embedding for Extreme Environments
PatSnap Eureka Unknown Overview Novel polymer-based nanocomposites are revolutionizing wearable sensor chip embedding by significantly enhancing mechanical, thermal, and barrier properties, paving the way for advanced applications in aer... -
Multi-Walled Carbon Nanotubes Supercharge Li-ion Batteries: 3-10x Performance Boost at Competitive Costs
Cheap Tubes USA Overview Carbon Nanotubes (CNTs) are emerging as transformative conductive additives for lithium-ion batteries, delivering 3-10 times the performance enhancement of traditional carbon black with significantly reduced mate... -
FDA Issues New Draft Guidance to Accelerate Cell and Gene Therapy Development: Promoting Efficiency Through Prior Knowledge Utilization
FDA Press Announcements USA Overview The FDA announced new draft guidance on June 2, 2026, aimed at accelerating the development of cell and gene therapies. This guidance encourages sponsors to effectively leverage 'prior knowledge,' par... -
CRISPR Gene Editing Utilized: First Leishmaniasis Vaccine Receives FDA IND Approval, Advancing to Phase 1 Clinical Trial
Ohio State News USA Overview The first leishmaniasis vaccine, developed by researchers at Ohio State University, is set to begin a Phase 1 clinical trial after receiving Investigational New Drug (IND) approval from the FDA. This innovati... -
Fate Therapeutics’ iPSC-Derived CAR T Therapy FT836 Shows Tumor Reduction and Favorable Safety Profile in KRASwt Colorectal Cancer Phase 1 Data at ASCO
GlobeNewswire (Fate Therapeutics Press Release) USA Overview Fate Therapeutics presented preliminary Phase 1 clinical data for its iPSC-derived, off-the-shelf CAR T-cell therapy, FT836, at the 2026 American Society of Clinical Oncology (... -
Tempus AI and Roswell Park Unveil Groundbreaking AI Algorithms for Pancreatic Cancer and Metastatic RCC at ASCO 2026
Tempus 他 USA Overview At the 2026 ASCO Annual Meeting, Tempus AI and Roswell Park Comprehensive Cancer Center announced significant advancements in AI-driven oncology, showcasing novel algorithms designed to revolutionize cancer diagnos... -
Evolution of Leading Generative AI Foundation Models: Google Gemini 3.5 Flash and Anthropic Claude Opus 4.8 Series Emerge
Amquest Education India Overview As of mid-2026, leading generative AI foundation models include Google DeepMind's Gemini 3.5 Flash and Gemini 3.1 Pro, noted for their native multimodal capabilities and competitiveness against GPT-5 clas... -
AI Accelerates Drug Discovery by Rapidly Screening Candidate Molecules from Large Datasets, Augmenting Scientific Judgment and Reducing Time-to-Market
MedCity News USA Overview AI in drug discovery accelerates processes by efficiently sifting through large datasets of candidate molecules to evaluate properties like potency and selectivity, thereby augmenting scientific judgment and red... -
Google AI Edge Achieves 19.6ms Low-Latency On-Device AI with LiteRT GPU Accelerator on Samsung Galaxy S24
Google AI Edge USA Overview Google AI Edge announced advancements in its LiteRT GPU Accelerator, which, while not yet open-sourced, is available as prebuilts for Kotlin and C++ SDK users. Benchmark results on a Samsung Galaxy S24 device ...
